Results 91 to 100 of about 29,053 (244)
Glucagonoma and Glucagonoma Syndrome: An Updated Review
ABSTRACT Background Glucagonoma is a rare well‐differentiated slowly proliferating pancreatic neuroendocrine tumour, characterized by several manifestations including necrolytic migratory erythema, weight loss, diabetes and anaemia. Aim The purpose of the current review was to acknowledge literature about this rare tumour discerning the clinical ...
Sofia Anelli+8 more
wiley +1 more source
ABSTRACT Objective Ureteral strictures, a common complication of ureteral stone treatment, pose substantial challenges. These conditions often necessitate robot‐assisted ureteral reconstruction (RUR), a procedure complicated by difficulty in identifying and mobilizing adhesive ureters.
Kazumi Taguchi+7 more
wiley +1 more source
Abstract Patients with bulky neuroendocrine liver metastases (NELM) undergoing PRRT with [177Lu]Lu‐DOTATATE have a worse survival than patients with limited liver metastases. Previously, the safety and efficacy of additional selective internal radiotherapy (SIRT), using holmium‐166 (166Ho)‐microspheres, directly following PRRT in patients with NELM ...
W. B. Veldhuis+14 more
wiley +1 more source
Abstract Pancreatic neuroendocrine tumors (panNETs) are rare pediatric malignancies with age‐specific clinical and biological features. Data on their presentation, management, and outcomes remain limited. This retrospective study analyzed 28 pediatric panNET cases from the German Malignant Endocrine Tumor (MET) Registry enrolled between 1997 and 2024 ...
Katharina Karges+12 more
wiley +1 more source
Radionuclide tumour therapy with ultrasound contrast microbubbles [PDF]
Annemieke van Wamel+4 more
openalex +1 more source
The impact of re‐characterizing metastatic pancreatic neuroendocrine tumors: A prospective study
Abstract The biology of metastatic pancreatic neuroendocrine tumors (panNET) may alter over time. It remains to be defined if, how, and when this patient group should be recommended to re‐evaluate the characteristics of their disease. This prospective single‐center, longitudinal cohort study at Uppsala University Hospital, Sweden (NCT03130205 ...
Kazhan Mollazadegan+9 more
wiley +1 more source
Abstract Patients with gastroenteropancreatic–neuroendocrine tumors (GEP‐NETs) may present skeletal fragility that might be related to multiple factors, including bone metastases, vitamin D deficiency, hormone secretion, and disease treatments. This study examines the prevalence and determinants of fragility fractures in low grading (G1‐G2) GEP‐NETs ...
Alessandro Brunetti+15 more
wiley +1 more source
Controversies in NEN: An ENETS position statement on nutritional support in neuroendocrine neoplasms
Abstract Neuroendocrine neoplasms (NEN) themselves and also their treatment may cause malnutrition, inducing changes in physiological behaviour and eventually leading to increased rates of morbidity and mortality. Malnutrition is a common, under‐recognised and under‐treated condition in patients with NEN, and there are limited data available on the ...
Simona Grozinsky‐Glasberg+53 more
wiley +1 more source
This systematic review aims to determine whether MVS reduces the incidence of VA and SCD in patients with MVP. Available studies show a likely reduction when surgery is performed in line with current guideline‐directed indications; however, a residual risk of VA and SCD remains.
James N. Cameron+12 more
wiley +1 more source
Combination of dosimetry for targeted radionuclide and external beam therapies [PDF]
Rachel K. Bodey
openalex +1 more source